IP Library › Assignment 033435/0126
Patent Assignment
Reel/Frame 033435/0126

Assignment of Assignor's Interest

Recorded: 2014-07-31 Pages: 12
Assignor
ALNYLAM PHARMACEUTICALS, INC.
Executed: 2012-12-05
Assignee
TEKMIRA PHARMACEUTICALS CORPORATION
100 - 8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property (1)
Lipid Formulations
Patent: 9,394,234 →
Application: 14/319,996 →
Publication: US 2015/0166465
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 31, 2014
From: CHEN, JIANXIN; ANSELL, STEVEN; AKINC, AKIN; DORKIN, JOSEPH ROBERT
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 033435/0159 →
Change of Name May 19, 2016
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 038646/0652 →
Merger and Change of Name Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →